Chengwu X. Zhang
158 Shangtang Road
Hangzhou, 310014, China
Hangzhou, 310014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Tertiary lymphoid structures (TLS): The mechanism hub and therapeutic target of neoadjuvant immunotherapy for hepatocellular carcinoma.
Journal: Critical reviews in oncology/hematology
Published: April 24, 2026
Dark tea-derived exosome-like nanovesicles suppress hepatocellular carcinoma via inhibiting Akt pathway and modulating immune profiles.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 23, 2026
Robotic versus laparoscopic spleen-preserving distal pancreatectomy: a propensity score-matched study of the "splenic artery and vein plane first" strategy.
Journal: Journal of robotic surgery
Published: February 23, 2026
Matrix stiffness-induced YEATS2 drives HCC progression via epigenetic activation of the TGFBR2-TAZ-AKT pathway.
Journal: Cell death and differentiation
Published: July 29, 2025
Dual enzyme-driven redox homeostasis disruption with ultrasmall Pt-decorated MoS2 for combined ferroptosis therapy of hepatocellular carcinoma.
Journal: Materials today. Bio
Published: July 29, 2025
A clinically applicable machine learning model for personalized survival prediction in metastatic pancreatic neuroendocrine tumors.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 02, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial.
Journal: Signal transduction and targeted therapy
Published: January 18, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: November 13, 2024
Evolution from laparoscopic to robotic radical resection for gallbladder cancer: a propensity score-matched comparative study.
Journal: Surgical endoscopy
Published: July 18, 2024
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a single-center propensity score matching analysis.
Journal: Scientific reports
Published: February 25, 2024
Machine learning-based diagnostic model for preoperative differentiation between xanthogranulomatous cholecystitis and gallbladder carcinoma: a multicenter retrospective cohort study.
Journal: Frontiers in oncology
Published: December 14, 2023
Last Updated: 09/26/2026